CollPlant Biotechnologies GAAP EPS of -$0.13 misses by $0.09, revenue of $2.06M misses by $0.6M
Source: SeekingAlpha
2025-05-28 07:01:23 ET
More on CollPlant Biotechnologies
- CollPlant Biotechnologies Ltd. (CLGN) Q4 2024 Earnings Call Transcript
- Collplant plans clinical trials for dermal filler and advances regenerative implants
- Seeking Alpha’s Quant Rating on CollPlant Biotechnologies
- Historical earnings data for CollPlant Biotechnologies
- Financial information for CollPlant Biotechnologies
Read the full article on Seeking Alpha
For further details see:
CollPlant Biotechnologies GAAP EPS of -$0.13 misses by $0.09, revenue of $2.06M misses by $0.6M
CollPlant Holdings Ltd.
NASDAQ: CLGN
CLGN Trading
-1.9% G/L:
$0.6082 Last:
18,795 Volume:
$0.6001 Open:
CLGN Latest News
CLGN Stock Data
$8,706,044
9,102,937
N/A
15
N/A
Biotechnology & Life Sciences
Healthcare
IL
Rehovot
